EUVIMEDEUVIMED entdecken
Crossref

Triglyceride‐Glucose Index in Parotid Gland Tumours: A Novel Biomarker for Differentiating Warthin Tumour and Pleomorphic Adenoma

Remzi Dogan iD, Ramazan Bahadır Kucuk iD, Alper Yenigun iD, Elif Ece Dogan iD, Orhan Ozturan iD

Clinical Otolaryngology · 2026

DOI: 10.1111/coa.70088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Otolaryngology, 2026. Verfasst von Remzi Dogan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Faculty of Medicine, Bezmialem Vakif University, Fatih, Istanbul, Turkey. Hauptthemen laut MEDLINE: Parotid Neoplasms, Adenolymphoma, Adenoma, Pleomorphic, Triglycerides. Die Arbeit nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pleomorphic adenoma and Warthin tumour are the two most common benign parotid gland tumours with distinct histological and clinical profiles. Recent studies suggest a potential link between metabolic disturbances—particularly insulin resistance—and the development of Warthin tumours. The triglyceride‐glucose (TyG) index has emerged as a simple, cost‐effective biomarker of insulin resistance. This study aimed to investigate the potential role of the TyG index in differentiating between pleomorphic adenoma and Warthin tumour.

Methods

A retrospective cross‐sectional study was conducted on patients histopathologically diagnosed with pleomorphic adenoma ( n = 31) or Warthin tumour ( n = 22), and compared with healthy controls ( n = 58). Fasting glucose and triglyceride levels were used to calculate the TyG index. Statistical analyses included t ‐tests, ANOVA, and Bonferroni‐corrected post hoc comparisons, with a significance threshold of p < 0.05.

Results

No significant differences were observed in age, sex, BMI or TyG index between the tumour group and controls. However, the TyG index was significantly higher in the Warthin tumour group (4.91 ± 0.28) compared to the pleomorphic adenoma (4.68 ± 0.31, p = 0.006) and control groups (4.72 ± 0.23, p = 0.033). No difference was found between the pleomorphic adenoma and control groups.

Conclusion

The TyG index is significantly elevated in patients with Warthin tumours, supporting its potential role as a simple, non‐invasive biomarker to aid in the differential diagnosis of benign parotid tumours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parotid NeoplasmsAdenolymphomaAdenoma, PleomorphicTriglyceridesBlood GlucoseHumansFemaleRetrospective StudiesDiagnosis, DifferentialMaleCross-Sectional StudiesMiddle AgedBiomarkers, TumorAdultBiomarkersAged

Stichwörter der Autor:innen

Warthin tumourbiomarkersmetabolic indicatorsparotid gland tumourspleomorphic adenomatriglyceride‐glucose index

Substanzen

TriglyceridesBiomarkers, TumorBlood GlucoseBiomarkers

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Faculty of Medicine, Bezmialem Vakif University, Fatih, Istanbul, Turkey.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

ORCID-Profile: Remzi Dogan, Ramazan Bahadır Kucuk, Alper Yenigun, Elif Ece Dogan, Orhan Ozturan

Zitieren

APA

Dogan, R., Kucuk, R. B., Yenigun, A., Dogan, E. E., & Ozturan, O. (2026). Triglyceride‐Glucose Index in Parotid Gland Tumours: A Novel Biomarker for Differentiating Warthin Tumour and Pleomorphic Adenoma. Clinical Otolaryngology. https://doi.org/10.1111/coa.70088

Vancouver

Dogan R, Kucuk RB, Yenigun A, Dogan EE, Ozturan O. Triglyceride‐Glucose Index in Parotid Gland Tumours: A Novel Biomarker for Differentiating Warthin Tumour and Pleomorphic Adenoma. Clinical Otolaryngology. 2026. doi:10.1111/coa.70088

BibTeX
@article{Dogan2026,
  author = {Dogan, Remzi and Kucuk, Ramazan Bahadır and Yenigun, Alper and Dogan, Elif Ece and Ozturan, Orhan},
  title = {Triglyceride‐Glucose Index in Parotid Gland Tumours: A Novel Biomarker for Differentiating Warthin Tumour and Pleomorphic Adenoma},
  journal = {Clinical Otolaryngology},
  year = {2026},
  doi = {10.1111/coa.70088}
}
Kostenlos starten →